A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk
Public ClinicalTrials.gov record NCT00412113. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-Week, Prospective, Randomized, Double-Blind, Double-Dummy Phase IV Clinical Trial Designed to Evaluate the Efficacy of an Aggressive Multi-Risk Factor Management Strategy With Caduet (A3841045) Versus a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensive Subjects With Additional Risk Factors.
Study identification
- NCT ID
- NCT00412113
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Industry
- Enrollment
- 245 participants
Conditions and interventions
Conditions
Interventions
- Amlodipine besylate Drug
- Amlodipine besylate/atorvastatin calcium single pill combination Drug
Drug
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2006
- Primary completion
- Mar 31, 2008
- Completion
- Mar 31, 2008
- Last update posted
- Feb 10, 2021
2007 – 2008
United States locations
- U.S. sites
- 51
- U.S. states
- 23
- U.S. cities
- 47
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Birmingham | Alabama | 35209 | — |
| Pfizer Investigational Site | Birmingham | Alabama | 35216 | — |
| Pfizer Investigational Site | Birmingham | Alabama | 35234 | — |
| Pfizer Investigational Site | Mesa | Arizona | 85206 | — |
| Pfizer Investigational Site | Garden Grove | California | 92843 | — |
| Pfizer Investigational Site | Mission Viejo | California | 92692 | — |
| Pfizer Investigational Site | Rancho Santa Margarita | California | 92688 | — |
| Pfizer Investigational Site | Torrance | California | 90502 | — |
| Pfizer Investigational Site | Gainesville | Florida | 32605 | — |
| Pfizer Investigational Site | Kissimmee | Florida | 34741 | — |
| Pfizer Investigational Site | Melbourne | Florida | 32935 | — |
| Pfizer Investigational Site | Miami | Florida | 33176 | — |
| Pfizer Investigational Site | Safety Harbor | Florida | 34695 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33701 | — |
| Pfizer Investigational Site | Augusta | Georgia | 30904 | — |
| Pfizer Investigational Site | Tucker | Georgia | 30084 | — |
| Pfizer Investigational Site | South Bend | Indiana | 46601 | — |
| Pfizer Investigational Site | Erlanger | Kentucky | 41018 | — |
| Pfizer Investigational Site | Auburn | Maine | 04210 | — |
| Pfizer Investigational Site | Warren | Michigan | 48091 | — |
| Pfizer Investigational Site | Minneapolis | Minnesota | 55404 | — |
| Pfizer Investigational Site | Chesterfield | Missouri | 63017 | — |
| Pfizer Investigational Site | Florissant | Missouri | 63031 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68116-2004 | — |
| Pfizer Investigational Site | Henderson | Nevada | 89014 | — |
| Pfizer Investigational Site | Henderson | Nevada | 89015 | — |
| Pfizer Investigational Site | Belvidere | New Jersey | 07823 | — |
| Pfizer Investigational Site | Bridgewater | New Jersey | 08807 | — |
| Pfizer Investigational Site | Clifton | New Jersey | 07013 | — |
| Pfizer Investigational Site | Elizabeth | New Jersey | 07202 | — |
| Pfizer Investigational Site | Hillsborough | New Jersey | 08844 | — |
| Pfizer Investigational Site | Trenton | New Jersey | 08618 | — |
| Pfizer Investigational Site | Brooklyn | New York | 11229 | — |
| Pfizer Investigational Site | Buffalo | New York | 14209 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45219 | — |
| Pfizer Investigational Site | Cincinnati | Ohio | 45242 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73103 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74136 | — |
| Pfizer Investigational Site | Bensalem | Pennsylvania | 19020 | — |
| Pfizer Investigational Site | Lansdale | Pennsylvania | 19446 | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | 19146 | — |
| Pfizer Investigational Site | Providence | Rhode Island | 02904 | — |
| Pfizer Investigational Site | Goose Creek | South Carolina | 29445 | — |
| Pfizer Investigational Site | Mt. Pleasant | South Carolina | 29464 | — |
| Pfizer Investigational Site | Bristol | Tennessee | 37620 | — |
| Pfizer Investigational Site | Kingsport | Tennessee | 37660 | — |
| Pfizer Investigational Site | Dallas | Texas | 75235 | — |
| Pfizer Investigational Site | Houston | Texas | 77030-2324 | — |
| Pfizer Investigational Site | Plano | Texas | 75093 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78238 | — |
| Pfizer Investigational Site | Chesapeake | Virginia | 23320 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00412113, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 10, 2021 · Synced May 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00412113 live on ClinicalTrials.gov.